Metacare Co., Ltd. (118000) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Metacare Co., Ltd. (118000:KRX), powered by AI.

Current Price
₩223
P/E Ratio
3.6
Market Cap
38.3B
Sector
Healthcare
What is the Metacare Co., Ltd. stock price forecast?

Metacare Co., Ltd. is currently trading at ₩223. View real-time AI analysis on Alpha Lenz.

What is Metacare Co., Ltd. insider trading activity?

View the latest insider trading data for Metacare Co., Ltd. on Alpha Lenz.

What is Metacare Co., Ltd.'s P/E ratio?

Metacare Co., Ltd.'s P/E ratio is 3.6.

Metacare Co., Ltd.

KRX · 118000
₩223
Ask about Metacare Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Metacare Co., Ltd. trades at a P/E of 3.6 (undervalued) with solid ROE of 8.4%.

Ask for details

Company Overview

Metacare Co., Ltd. is a key player in the healthcare sector, primarily focused on providing a wide array of healthcare solutions. The company's core operations include the development, manufacturing, and distribution of medical equipment and supplies, catering to both domestic and international markets. Metacare Co., Ltd. is dedicated to enhancing the quality of patient care through innovative technologies and products, enabling healthcare providers to deliver efficient and effective treatments. Their product portfolio is extensive, encompassing diagnostic tools, surgical devices, and patient monitoring systems. Through continual research and development initiatives, Metacare Co., Ltd. strives to stay at the forefront of medical innovation, addressing evolving healthcare needs and challenges. The company plays a critical role in the healthcare ecosystem, supporting hospitals, clinics, and medical professionals by supplying essential tools that promote better health outcomes. With its commitment to reliability and quality, Metacare Co., Ltd. is a significant entity within the medical technology industry, contributing to advancements in patient care and healthcare delivery on a global scale.

CEO이수진
SectorHealthcare
IndustryDrug Manufacturers - General
Employees31

Company Statistics

FY 2024

Profile

₩38,306,352,172Market Cap
₩20,208,077,610Revenue
171.78MShares Out
31Employees

Margins

37.97%Gross
53.02%EBITDA
7.45%Operating
13.24%Pre-Tax
41.44%Net

Valuation

3.64P/E
0.29P/B
1.67EV/Sales
3.66EV/EBITDA
21.38P/FCF

Growth (CAGR)

2.78%Rev 3Yr
-18.49%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
2.48%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

5.37%ROA
8.37%ROE
1.97%ROIC

Financial Health

₩30,061,489,530Cash & Cash Equivalents
₩10,960,447,830Net Debt
35.46%Debt/Equity
N/AInterest Cov
Alpha Chat Insight

Metacare Co., Ltd. trades at a P/E of 3.6 (undervalued) with solid ROE of 8.4%.

Ask for details

Frequently Asked Questions

Metacare Co., Ltd. (ticker: 118000) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - General). It has approximately 31 employees. Market cap is $38.3B.

The current price is ₩223 with a P/E ratio of 3.64x and P/B of 0.29x.

ROE is 8.37% and operating margin is 7.45%. Annual revenue is $20.2B.

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Metacare Co., Ltd. (Healthcare) Stock Forecast & Analysis ₩223 | Alpha Lenz